Clinical Trial Update: Evaluation of Fluoxetine for Refractory Constipation With Somatic Symptom Disorder Features [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial is evaluating fluoxetine, an SSRI, for refractory constipation with features of somatic symptom disorder in Phase 1/Phase 2, and the study is n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Constipation
• Functional Constipation
• Somatic Symptom Disorder

Drugs mentioned

• Fluoxetine (Fluoxetine)
• Prozac (Fluoxetine)

Snippet

Sponsor: Zhifeng Zhao, PhD | Conditions: Refractory Constipation, Somatic Symptom Disorder (DSM-5) | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING